The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Aptose Biosciences Inc(NASDAQ:APTO) 
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase 1a/b clinical trial for the treatment of patients with relapsed or refra...
Website: http://www.aptose.com
Founded: 2014
Full Time Employees: 31
Sector: Healthcare
Industry: Biotechnology
Aptose Biosciences Days Payable Outstanding ttm (DPO)
Aptose Biosciences Op Cashflow Per Share ttm
Aptose Biosciences Free Cashflow Per Share ttm
Aptose Biosciences Cash Per Share ttm
Aptose Biosciences (GAAP) P/E ratio ttm
Aptose Biosciences P/B ratio ttm
No extra charts and metrics for this ticker.